SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000850261-19-000014
Filing Date
2019-04-23
Accepted
2019-04-23 21:02:14
Documents
1
Period of Report
2019-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155606772031203.html 4  
1 FORM 4 wf-form4_155606772031203.xml 4 4002
  Complete submission text file 0000850261-19-000014.txt   5462
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address
Janda Kim (Reporting) CIK: 0001518466 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 19762461